Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | Impact of the microbiota GvHD and post-transplant survival outcomes

Florent Malard, MD, PhD, Saint Antoine Hospital, Paris, France, provides updates on the role of the microbiota in graft versus host disease (GvHD) pathophysiology. Dr Malard highlights the contribution of fungi and viruses in transplant survival rates; presence of the fungus Candida albicans is associated with inferior survival rates in patients undergoing transplant. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.